| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51662-1426-1 | 51662-1426 | HUMAN PRESCRIPTION DRUG | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | INJECTION, SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20200110 | N/A | ANDA | ANDA207634 | HF Acquisition Co LLC, DBA HealthFirst | NALOXONE HYDROCHLORIDE | .4 mg/mL | 1 VIAL, GLASS in 1 CARTON (51662-1426-1) / 10 mL in 1 VIAL, GLASS |
| 70069-072-10 | 70069-072 | HUMAN PRESCRIPTION DRUG | Naloxone Hydrochloride | Naloxone Hydrochloride | INJECTION, SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20170726 | N/A | ANDA | ANDA207634 | Somerset Therapeutics, LLC | NALOXONE HYDROCHLORIDE | .4 mg/mL | 10 CARTON in 1 BOX (70069-072-10) / 1 VIAL, GLASS in 1 CARTON (70069-072-01) / 10 mL in 1 VIAL, GLASS |